KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Omega Healthcare Investors (OHI) EBITDA (2016 - 2026)

Omega Healthcare Investors' EBITDA history spans 16 years, with the latest figure at $209.7 million for Q1 2026.

  • On a quarterly basis, EBITDA rose 25.65% to $209.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $882.3 million, a 29.81% increase, with the full-year FY2025 number at $839.5 million, up 30.66% from a year prior.
  • EBITDA hit $209.7 million in Q1 2026 for Omega Healthcare Investors, down from $223.0 million in the prior quarter.
  • Over the last five years, EBITDA for OHI hit a ceiling of $252.9 million in Q1 2022 and a floor of $93.3 million in Q1 2023.
  • Historically, EBITDA has averaged $167.8 million across 5 years, with a median of $166.0 million in 2024.
  • Biggest five-year swings in EBITDA: tumbled 63.12% in 2023 and later skyrocketed 50.24% in 2025.
  • Tracing OHI's EBITDA over 5 years: stood at $106.5 million in 2022, then increased by 13.87% to $121.3 million in 2023, then surged by 43.41% to $173.9 million in 2024, then rose by 28.27% to $223.0 million in 2025, then fell by 5.99% to $209.7 million in 2026.
  • Business Quant data shows EBITDA for OHI at $209.7 million in Q1 2026, $223.0 million in Q4 2025, and $249.5 million in Q3 2025.